Showing results (1681-1690 of 4,889) with videos related to
Sort By:
Pageof 489
Science Translational Medicine|September 9, 2011
Hidden immunotherapy targets challenge dogmaSoldano FerroneScience Translational Medicine|September 9, 2011
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximabKimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, et al.Science Translational Medicine|August 12, 2011
Type 1 diabetes immunotherapy: is the glass half empty or half full?Kevan C Herold, Jeffrey A BluestoneScience Translational Medicine|December 23, 2011
Mapping the road forward in Alzheimer's diseaseDavid M Holtzman, Alison Goate, Jeffrey Kelly, et al.Science Translational Medicine|January 21, 2012
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patientsRachael A Clark, Rei Watanabe, Jessica E Teague, et al.Science Translational Medicine|February 21, 2012
Viral and inflammatory triggers of neurodegenerative diseasesMichela Deleidi, Ole IsacsonScience Translational Medicine|February 21, 2012
MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathwaysB Nelson Chau, Cuiyan Xin, Jochen Hartner, et al.Science Translational Medicine|January 13, 2012
Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomasAdam Elkhaled, Llewellyn E Jalbert, Joanna J Phillips, et al.Science Translational Medicine|December 3, 2011
Testing the right target and right drug at the right stageReisa A Sperling, Clifford R Jack, Paul S AisenScience Translational Medicine|December 3, 2011
miRNA processing and human cancer: DICER1 cuts the mustardAmin Bahubeshi, Marc Tischkowitz, William D FoulkesPageof 489